Testing Escitalopram against a placebo for major depressive disorder
Explore this study →
There are 4 groups in this study. Groups A and C, the comparison group, receive Escitalopram and Brexpiprazole. Groups B and D, the placebo group, receive Escitalopram.
Sites in Toronto, Calgary and 7 more cities
- Phase 4
- 4 groups
- Sites in Calgary, Vancouver and 7 more cities
- Recruiting
Official title: Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Major Depressive Disorder · Nova Scotia Health Authority